Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass
NCT ID: NCT05593627
Last Updated: 2023-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
62 participants
INTERVENTIONAL
2023-07-01
2026-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Characterizations of Gut Microbiota and Postoperative Sleep in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass
NCT05136001
Ischemic Postconditioning in Carotid Surgery
NCT06359756
Effects of AI Assisted Follow-up Strategy on Secondary Prevention in CABG Patients
NCT04636996
Sleep-disordered Breathing and Perioperative Atrial Fibrillation in Cardiac Surgery
NCT02877745
Monitored Anesthesia Care Versus Intubated General Anesthesia for Open Heart Surgery Under Cardiopulmonary Bypass
NCT05011617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lithium carbonate
Patients undergoing heart valve surgery with cardiopulmonary bypass will take 250mg lithium carbonate .
Lithium Carbonate 250 MG Oral Tablet
Patients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate
calcium carbonate
Patients undergoing heart valve surgery with cardiopulmonary bypass will take 500mg calcium carbonate.
Calcium Carbonate 500 MG Oral Tablet
Patients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lithium Carbonate 250 MG Oral Tablet
Patients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate
Calcium Carbonate 500 MG Oral Tablet
Patients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age, 18 to 65 years old;
* Patients undergoing heart valve surgery with cardiopulmonary bypass
Exclusion Criteria
* Cognitive difficulties
* Partial or complete gastrectomy
* Previous esophageal surgery
* Previous treated by radiotherapy or surgery
* Inability to conform to the study's requirements
* Body mass index exceeding 30 kg/m2
* Deprivation of a right to decide by an administrative or juridical entity
* Ongoing participation or participation in another study \<1 month ago
* Recent (\< 3 months prior) use of antibiotics, probiotics, prebiotics, symbiotics, hormonal medication, laxatives, proton pump inhibitors, insulin sensitizers or traditional Chinese medicine
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China Medical University, China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wenfei Tan
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
the First Hospital of China Medical University
Shenyang, Liaoning, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20220920-03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.